Search Page

1

Cite

Share

Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

Torumkuney D, Bratus E, Yuvko O, Pertseva T, Morrissey I. Torumkuney D, et al. Among authors: pertseva t. J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i100-i111. doi: 10.1093/jac/dkaa087. J Antimicrob Chemother. 2020. PMID: 32337596

Cite

Share

2

Cite

Share

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.

Torumkuney D, Pertseva T, Bratus E, Dziublik A, Yachnyk V, Liskova A, Sopko O, Malynovska K, Morrissey I. Torumkuney D, et al. Among authors: pertseva t. J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v28-v35. doi: 10.1093/jac/dky069. J Antimicrob Chemother. 2018. PMID: 29659885

Cite

Share

3

Cite

Share

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.

Torumkuney D, Pertseva T, Bratus E, Dziublik A, Yachnyk V, Liskova A, Sopko O, Malynovska K, Morrissey I. Torumkuney D, et al. Among authors: pertseva t. J Antimicrob Chemother. 2018 Aug 1;73(8):2276. doi: 10.1093/jac/dky220. J Antimicrob Chemother. 2018. PMID: 29901766 No abstract available.

Cite

Share

4

Cite

Share

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.

Feshchenko Y, Dzyublik A, Pertseva T, Bratus E, Dzyublik Y, Gladka G, Morrissey I, Torumkuney D. Feshchenko Y, et al. Among authors: pertseva t. J Antimicrob Chemother. 2016 May;71 Suppl 1(Suppl 1):i63-9. doi: 10.1093/jac/dkw068. J Antimicrob Chemother. 2016. PMID: 27048583 Free PMC article.

Cite

Share

5

Cite

Share

A new perspective on bronchial asthma and chronic obstructive pulmonary disease overlap: potential diagnostic criteria.

Pertseva TO, Konopkina LI, Babenko AO. Pertseva TO, et al. Wiad Lek. 2020;73(7):1480-1483. Wiad Lek. 2020. PMID: 32759441

Cite

Share

6

Cite

Share

THE FORECAST OF LETHAL OUTCOME IN CHRONIC LEUKEMIA PATIENTS WITH PNEUMONIA.

Pertseva T, Borysova I. Pertseva T, et al. Georgian Med News. 2019 Mar;(288):91-97. Georgian Med News. 2019. PMID: 31101784

Cite

Share

7

Cite

Share

Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.

Corren J, Mansfield LE, Pertseva T, Blahzko V, Kaiser K. Corren J, et al. Among authors: pertseva t. Respir Med. 2013 Feb;107(2):180-95. doi: 10.1016/j.rmed.2012.10.025. Epub 2012 Dec 25. Respir Med. 2013. PMID: 23273405 Free article. Clinical Trial.

Cite

Share

8

Cite

Share

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.

Papi A, Mansur AH, Pertseva T, Kaiser K, McIver T, Grothe B, Dissanayake S. Papi A, et al. Among authors: pertseva t. J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):346-61. doi: 10.1089/jamp.2015.1255. Epub 2016 Apr 22. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 27104231 Free PMC article.

Cite

Share

9

Cite

Share

Diagnostic role of systemic inflammation, blood coagulation and padua prediction score in lung thrombosis risk estimation in hospitalized patients with community-acquired pneumonia.

Pertseva T, Kireieieva T, Krykhtina M, Bielosludtseva K, Dyagovets K. Pertseva T, et al. Wiad Lek. 2019;72(2):149-153. Wiad Lek. 2019. PMID: 30903763

Cite

Share

10

Cite

Share

Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial.

Pertseva T, Dissanayake S, Kaiser K. Pertseva T, et al. Curr Med Res Opin. 2013 Oct;29(10):1357-69. doi: 10.1185/03007995.2013.825592. Epub 2013 Aug 20. Curr Med Res Opin. 2013. PMID: 23865726 Clinical Trial.

Cite

Share